|
Etiology
No evidence is cited.
Epidemiology
No evidence is cited.
Diagnosis
Clinical Diagnosis
For the treatment of UTI in symptomatic
young women, the following strategies are listed in order of decreasing
cost-effectiveness:
-
Most cost-effective (least expensive) strategy:
-
Empirical treatment of symptomatic women
-
Less cost-effective (more expensive) strategy:
-
Treatment based on full urinalysis
-
Treatment with office culture to confirm sensitivity
-
Treatment with reference lab culture to confirm
sensitivity
-
Treatment after office culture results available
-
Treatment after reference lab results available
-
Least cost-effective (most expensive) strategy:
-
Treatment based on dipsticks
Since all treatment strategies were very effective
in terms of cure rate and quality of life, the empirical treatment of symptomatic
women is judged the most cost-effective strategy.
-
Caveats
-
Age group studied: Young adult
-
Type/size: Decision analysis
-
Population characteristics: Healthy woman
with dysuria for <1 week without vaginal discharge, signs of pyelonephritis
or predisposing factors such as diabetes
-
Outcome measures: cure without complications,
pyelonephritis, persistent dysuria requiring reassessment, urethritis,
vaginitis, other medication side-effects, quality adjusted life months
-
Only grossly different assumptions regarding
the cost of lab tests, physician time, drugs and hospital care would change
the results
-
Citations
Laboratory/X-ray Diagnosis
No evidence is cited.
Treatment
Antibiotics
Trimethoprim-sulphamethoxazole (160 mg/800
mg, twice daily x 3d) was more effective and least costly in treating UTI
in young women than were macrocrystalline nitrofurantoin (100 mg four times
a day x 3d), cefadroxil (500 mg twice daily x 3d) or amoxicillin (500 mg
three times daily x 3d). In another study trimethoprim alone was as effective
as trimethoprim-sulphamethoxazole.
-
Caveats
-
Age group studied: Young women
-
Type/size: RCT of 149 patients
-
Population characteristics: students presenting
to a student health center with symptoms of acute cystitis including dysuria,
frequency, urgency and/or suprapubic pain
-
Outcome measures: Cure at 6 weeks
-
Citations
Cefprozil, cefpodoxime proxetil, loracarbef,
cefixime, and ceftibuten appear to be as clinically effective as (but not
more effective than) conventional therapies (usually amoxicillin/clavulanate,
cefaclor or cephalexin) for the treatment of common community-acquired
infections, including acute otitis media, pharyngitis, sinusitis, bronchitis,
pneumonia, urinary tract infection and skin and skin-structure infections.
-
Caveats
-
Age group studied: Unknown
-
Type/Size: Analytical review of studies: acute
otitis media: 19 studies, pharyngitis: 13 studies, sinusitis: 4 studies,
bronchitis: 10 studies, pneumonia: 7 studies, urinary tract infection:
11 studies, skin and skin-structure infections: 4 studies. Most studies
consisted of 30-50 patients in each arm
-
Population: Unknown
-
Outcome measure: Clinical response to therapy
-
For some of these infections other studies
show that there is no evidence that any antibiotic therapy is beneficial
-
Citations
Seven days of antibiotic therapy for symptomatic
UTI in young healthy women is more cost-effective than 1- or 3-day regimens.
-
Caveats
-
Age group studied: Young adult
-
Type/size: Decision analysis
-
Population characteristics: Healthy woman
with dysuria for <1 week without vaginal discharge, signs of pyelonephritis
or predisposing factors such as diabetes
-
Outcome measures: cure without complications,
pyelonephritis, persistent dysuria requiring reassessment, urethritis,
vaginitis, other medication side-effects, quality adjusted life months
-
Only grossly different assumptions regarding
the cost of lab tests, physician time, drugs and hospital care would change
the results
-
Citations
Single dose antibiotic treatment (amoxicillin,
bacampicilin, cefaclor, cefadroxil, cefuroxime, doxycycline, nitrofurantoin,
pefloxacin, pivnecilinam, trimethoprim/sulfamethoxazole) of urinary tract
infection in women is less effective than conventional treatment (five
days or more), but causes fewer side effects.
-
Caveats
-
Age group studied: Adults
-
Type/size: Meta-analysis (25 trials = 2397
patients)
-
Population characteristics: Ambulatory women
with symptomatic, uncomplicated urinary tract infections
-
Outcome measures: Cure rates
-
Citations
Monitoring
No evidence is cited.
Prognosis
No evidence is cited.
Prevention
300 mL of a cranberry juice cocktail every
day reduces bacteriuria and pyuria and prevents UTI in high risk groups.
Blueberry juice may have a similar effect.
-
Caveats
-
Age group studied: Mean age 79 y
-
Type/size: RCT of 153 patients (= 818 urine
specimens)
-
Population characteristics: Women in whom
bacteriuria with pyuria was likely to have a high incidence (above 30%);
both inside (44) and outside (109) long-term care institutions
-
Outcome measures: Presence of bacteriuria
(defined as more than 100,000 organisms per mL) with pyuria
-
Citations
-
Drug
Watch: Cranberry juice reduces bacteriuria and pyuria - Reviewed by
Bandolier
-
Also: Howell
A et al, Inhibition of the Adherence of P-Fimbriated Escherichia coli to
Uroepithelial-Cell Surfaces by Proanthocyanidin Extracts from Cranberries,
NEJM, October 8, 1998, Volume 339, Number 15
-
Also: Kontiakari
T et al, Randomised Trial of Cranberry-Lingonberry Juice and Lactobacillus
GG Drink for the Prevention of Urinary Tract Infections in Women, BMJ,
June 30 2001, 322:1571-1573
Patient Education
The following patient education materials
are consistent with the available evidence.
Rev. 12/5/01
|